Back

PRIME Education, Inc. (PRIME®)

  • Adenocarcinoma
  • Immune Checkpoint Inhibitors

Immunity in Balance: Navigating Immune-Related Adverse Event Management With Checkpoint Inhibitors in Advanced Upper GI Adenocarcinomas

The integration of immune checkpoint inhibitors (ICIs) into the treatment of advanced upper gastrointestinal (GI) adenocarcinomas has introduced distinct toxicity profiles, making adverse event management essential for clinicians. In this interactive, case-based simulation you will assess and grade immune-related toxicities and apply evidence-based strategies for intervention, including appropriate corticosteroid use. In addition, you’ll explore approaches to multidisciplinary coordination and effective communication with patients and caregivers to improve patient outcomes. Strengthen your clinical confidence in managing ICI-associated adverse events in advanced upper GI cancers!

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Case-based learning
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    May 14, 2026
  • Last day to claim credit
    May 14, 2027 7 months left